Autosomal ichthyosis syndrome

Autosomal ichthyosis syndrome (Orphanet code 281217) is a broad classification grouping inherited disorders of keratinization that follow an autosomal pattern of inheritance (either dominant or recessive) and present with ichthyosis — widespread, persistent scaling of the skin — as a major feature alongside additional systemic manifestations. Unlike isolated (non-syndromic) ichthyosis, these syndromic forms involve abnormalities beyond the skin, potentially affecting the nervous system, eyes, hair, skeletal system, immune system, or other organs, depending on the specific subtype. Within this grouping, numerous distinct genetic conditions are recognized, including but not limited to Netherton syndrome, Sjögren-Larsson syndrome, CHILD syndrome (when autosomal forms are considered), ichthyosis with various neurological or metabolic features, and trichothiodystrophy with ichthyosis. Each subtype has its own causative gene(s), clinical course, and prognosis. Common features across many subtypes include generalized or patterned scaling of the skin, erythroderma (widespread skin redness), and variable degrees of extracutaneous involvement such as intellectual disability, spasticity, hair shaft abnormalities, growth retardation, or ocular findings. Treatment is largely supportive and symptomatic. Skin care typically involves regular use of emollients, keratolytic agents (such as urea- or lactic acid-based creams), and in some cases oral retinoids to reduce scaling. Management of extracutaneous manifestations requires a multidisciplinary approach involving dermatologists, neurologists, ophthalmologists, and other specialists as needed. Genetic counseling is important for affected families. No curative therapy currently exists for most autosomal ichthyosis syndromes, though research into gene therapy and targeted molecular treatments is ongoing.

Common questions about Autosomal ichthyosis syndrome